Padéryl 19.5 mg Codeine Sulphate
Brand name: Padéryl 19.5 mg Codeine Sulphate by Laboratories Gerda
Treatment: Managing mild to moderate pain.
Quantity per pack: 20 x 19.5 mg tablets
Price per pill: £1.75
Active Ingredient: Codeine Phosphate Hemihydrate
Padéryl 19.5 mg Codeine Sulphate is a medicine designed for managing mild to moderate pain. Codeine is normally only called upon where the person is in so much pain, that treatment with an opioid is the only option. And any alternative treatments are just simply inadequate.
Limitations of Use
With this medicine comes the risk of addiction, abuse, and misuse with opioids. Even at recommended doses , only use Padéryl 19.5 mg Codeine Sulphate if there are no alternative treatment options [e.g., non-opioid analgesics or opioid combination products]:
- Have not been tolerated, or are not expected to be tolerated,
- Have not provided adequate analgesia, or are not expected to provide adequate analgesia.
Dosage & Administration
- Always use the lowest effective dosage for the shortest duration for the patients individual needs.
- Dosage should be based on the amount of pain the patient is suffering. As well as how the patient responds, prior analgesic experience, and risk factors for addiction, abuse, and misuse.
- Common dosage recommendations are 15-60 mg every 4 hours as needed.
- Do not stop taking Codeine 19.5 mg Padéryl Sulfate tablets abruptly before the prescribed course is finished.
Adult doses higher than 60 mg provide no further efficacy. But are associated with greater adverse reactions. The maximum 24 hour dose is 360 mg.
Conversion from Other Opioids to Codeine 19.5 mg Padéryl Sulfate Tablets
There is inter-patient variability in the potency of opioid drugs and formulations. Therefore, a conservative approach is advised when determining the total daily dosage of Codeine 19.5 mg Padéryl Sulfate Tablets. It is safer to underestimate a patient’s 24-hour dosage than to overestimate the dosage and manage an adverse reaction due to overdose.
Titration and Maintenance of Therapy
Individually titrate Paderyl Sulfate Tablets to a dose that provides adequate analgesia and minimizes adverse reactions. Continually reevaluate patients receiving Paderyl sulfate to assess the maintenance of pain control and the relative incidence of adverse reactions, as well as monitoring for the development of addiction, abuse, or misuse . Frequent communication is important among the prescriber, other members of the healthcare team, the patient, and the caregiver/family during periods of changing analgesic requirements, including initial titration.
If the level of pain increases after dosage stabilization, attempt to identify the source of increased pain before increasing the Paderyl Sulfate Tablets dosage. If unacceptable opioid-related adverse reactions are observed, consider reducing the dosage. Adjust the dosage to obtain an appropriate balance between management of pain and opioid-related adverse reactions.
Discontinuation of Paderyl Sulfate
When a patient has been taking this medicine regularly they may have become dependant on it. Therefore, it is best to lower the dose gradually. by 25-50% every 2-4 days. While monitoring carefully for signs and symptoms of withdrawal. If the patient develops these signs or symptoms, raise the dose to the previous level. But this time taper more slowly, either by increasing the interval between decreases, decreasing the change in dose, or both. Do not abruptly discontinue this medicine in a physically-dependent patient.